For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | - | 8,000 | - | 0 |
| Research and development | 5,778,000 | 5,654,000 | 4,741,000 | 4,758,000 |
| General and administrative | 3,393,000 | 3,766,000 | 3,453,000 | 3,034,000 |
| Total operating expenses | 9,171,000 | 9,420,000 | 8,194,000 | 7,792,000 |
| Operating loss | -9,171,000 | -9,412,000 | -8,194,000 | -7,792,000 |
| Interest income | 173,000 | 128,000 | 175,000 | 224,000 |
| Bond accretion income | 70,000 | 37,000 | 69,000 | 112,000 |
| Total other income | 243,000 | 165,000 | 244,000 | 336,000 |
| Net loss | -8,928,000 | -9,247,000 | -7,950,000 | -7,456,000 |
| Unrealized loss on marketable securities | -14,000 | -34,000 | 5,000 | -26,000 |
| Comprehensive loss | -8,942,000 | -9,281,000 | -7,945,000 | -7,482,000 |
| Basic EPS | -0.2 | -0.245 | -0.21 | -0.2 |
| Diluted EPS | -0.2 | -0.245 | -0.21 | -0.2 |
| Basic Average Shares | 44,150,958 | 37,940,389 | 37,893,314 | 37,946,330 |
| Diluted Average Shares | 44,150,958 | 37,940,389 | 37,893,314 | 37,946,330 |
GENELUX Corp (GNLX)
GENELUX Corp (GNLX)